Evidence map›Paper›PMID 40240549›Full record

ArticleCurrent microbiology2025

Identification of Chlortetracycline Hydrochloride as a Antibacterial Compound Against Pseudomonas syringae pv. tomato DC3000 Through Natural Products Library Screening.

Lin Jiang, Linghe Huang, Yajing Wang, Jing Li, Zixian Zeng, Wenlong Yang, Sai Jiang, Dousheng Wu, Zhi Wang, Shunxiang Li and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lin JiangHunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Linghe HuangHunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Yajing WangHunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Jing LiDepartment of Pharmacy, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Cen-Tral South University, Changsha, 410008, China.
Zixian ZengHunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Wenlong YangHunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Sai JiangInstitute of Traditional Chinese Medicine for Innovation Drug Research, Hunan Academy of Chinese Medi-Cine, Changsha, 410013, China.
Dousheng WuHunan Key Laboratory of Plant Functional Genomics and Developmental Regulation, College of Biology, Hunan University, Changsha, 410082, China.
Zhi WangHunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Shunxiang LiHunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China. lishunxiang@hotmail.com.
Yanxia HuangHunan Engineering Technology Research Center for Bioactive Substance Discovery of Chinese Medicine, School of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China. 2316209603@qq.com.
Hong PuChina‑Pakistan International Science and Technology Innovation Cooperation Base for Ethnic Medicine De-velopment in Hunan Province, Hunan Provincial Key Laboratory for Synthetic Biology of Traditional Chinese Medicine, School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua, 418000, China. puhong@hnmu.edu.cn.

Funding

National Natural Science Foundation of China 82104055Scientific Research Foundation of Hunan Provincial Education Department 21A0246Scientific Research Foundation of Hunan Provincial Education Department 22B0396Scientific Research Foundation of Hunan Provincial Education Department 22B1036
6 · The paper itself

Abstract

Pseudomonas syringae (P. syringae) can infect over 50 different crops worldwide, causing significant economic losses, and it is one of the major bacterial pathogens affecting global crops. Currently, there are no effective control strategies for bacterial leaf spot disease caused by P. syringae. In this study, a high-throughput screening of 1680 natural products was conducted to evaluate their antibacterial effects. Microbial-derived compounds such as Polymyxin B sulfate (1), Methacycline hydrochloride (2), Tetracycline hydrochloride (3), Chlortetracycline hydrochloride (4), Demeclocycline hydrochloride (5), and Doxycycline hyclate (6) exhibited strong antibacterial activity against Pseudomonas syringae pv. tomato DC3000 (Pst DC3000), with inhibition rates exceeding 60%. Further research revealed that compound 4 had a minimum inhibitory concentration of 0.4 μM. After 12 h of treatment with 12.8 μM of compound 4, bacterial killing efficiency reached 98%. Moreover, compound 4 effectively inhibited the occurrence of bacterial leaf spot disease. In conclusion, this study suggests that microbial-derived natural products hold great potential as effective bactericides against Pst DC3000, providing a new approach for the control of bacterial leaf spot disease.

Indexed as

Anti-Bacterial AgentsBiological ProductsChlortetracyclinePseudomonas syringaeHigh-Throughput Screening AssaysMicrobial Sensitivity TestsPlant DiseasesAnti-Bacterial AgentsBiological ProductsChlortetracycline

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.